The research, led by investigators examining hospital-level adoption patterns across the United States, maps the diffusion of AI and robotic technologies through the American hospital system and connects those patterns to longstanding measures of access inequality. Rather than treating innovation as a rising tide that lifts all boats, the study treats each hospital’s adoption decision as the outcome of financial capacity, workforce readiness, regulatory environment, and patient demand. When those variables are mapped geographically, a stark pattern emerges: adoption clusters in large, urban, teaching-affiliated hospitals with high operating margins, while rural and safety-net institutions lag dramatically behind.

The technical logic behind this clustering is straightforward, and the authors unpack it in detail. Deploying a clinical machine learning model is not simply a matter of purchasing software. Hospitals must maintain the digital infrastructure to feed models with clean, standardized electronic health record data; they need data science personnel to validate, calibrate, and monitor algorithms over time; and they require the regulatory and governance frameworks to manage model drift, bias audits, and liability. Robotic surgical platforms add capital costs that can exceed two million dollars per system, plus recurring maintenance contracts and the need for surgeons trained on high procedural volumes. Each of these requirements scales with hospital size and revenue, giving well-resourced institutions a compounding advantage.

The study’s analysis of access inequality draws on the demographic and socioeconomic characteristics of the communities served by adopting and non-adopting hospitals. Patients in regions with early, intensive adoption tend to be wealthier, more likely to hold private insurance, and more likely to live in metropolitan counties with dense specialist networks. By contrast, rural hospitals, which serve roughly one in five Americans, frequently operate on thin or negative margins and cannot justify the capital expenditure or recruit the technical staff that AI-driven medicine demands. The result is a two-tier landscape in which the benefits of predictive analytics, automated diagnostics, and robot-assisted intervention accrue disproportionately to populations that already enjoy superior health outcomes.

What makes the finding more consequential is the mechanism by which early adoption generates future advantage. AI systems improve with data, and hospitals that deploy them early accumulate larger, better-labeled clinical datasets, refine their workflows sooner, and build institutional expertise that late adopters cannot easily replicate. Surgical outcomes for robot-assisted procedures are known to improve with surgeon and team experience, meaning hospitals with early robotic programs simultaneously achieve better results and attract more patients, further increasing volume and revenue. The authors characterize this as a potential cumulative-advantage dynamic, in which technological gaps do not merely persist but widen over time, the healthcare analogue of the winner-take-all economics seen in other data-driven industries.

The study also documents disparities in the types of technology being adopted. General administrative AI, such as scheduling optimization and billing automation, has diffused relatively broadly because its returns are immediate and its technical demands modest. Clinical AI, including diagnostic imaging support and risk prediction models, shows a much steeper socioeconomic gradient. Robotic surgical systems show the steepest gradient of all, concentrated overwhelmingly in high-volume urban centers. This stratification matters because clinical and surgical technologies are where the direct health benefits lie; administrative automation may improve a hospital’s finances without improving a single patient’s outcome.

Policy implications flow directly from the analysis. The authors point out that federal incentive programs, including the multibillion-dollar push toward electronic health records in the 2010s, succeeded partly because they tied payments to adoption, effectively subsidizing the transition. No comparable mechanism currently exists for clinical AI and robotics. Without deliberate intervention, market forces alone will continue to route innovation toward institutions that can afford it, a pattern the study suggests could entrench existing inequalities in mortality, disease detection, and surgical access. Potential remedies discussed include targeted grants and loan programs for rural and safety-net hospitals, shared-service models in which regional networks pool AI infrastructure, and reimbursement structures that reward outcomes rather than technology ownership.

The research also adds a cautionary note to the national conversation about AI in medicine, much of which has focused on algorithmic bias within individual models. A biased model deployed at a single hospital can harm that hospital’s patients, but a deployment gap between hospitals harms entire populations by denying them access to the technology at all. The study frames this second form of inequity, which the authors analyze at the system level rather than the algorithm level, as underexamined in the literature. Fairness auditing of individual models, the work implies, is necessary but not sufficient if the models themselves never reach the communities that need them most.

For clinicians, hospital administrators, and policymakers, the message of the study is that the window for shaping equitable adoption is now. Technological diffusion patterns harden as standards settle, vendor markets mature, and training pipelines consolidate around early adopters. The United States has already lived through versions of this story with MRI machines, positron emission tomography, and minimally invasive surgical platforms, each of which arrived in wealthy urban institutions years before reaching rural America. Whether AI and robotics follow the same trajectory or bend toward broader access depends on choices being made today, in state legislatures, federal agencies, and the boardrooms of hospital systems deciding where their next million-dollar investment will go. The evidence assembled here makes clear that leaving those choices to the market alone carries a predictable cost, and that the cost will be paid by the patients with the least capacity to bear it.

Subject of Research: Adoption of artificial intelligence and robotics in United States hospitals and its relationship to healthcare access inequality

Article Title: Hospital AI and robotics adoption and access inequality in the United States

Article References: Johnson, A., Gefen, D., & Harrison, T. D. (2026). Hospital AI and robotics adoption and access inequality in the United States. Scientific Reports. https://doi.org/10.1038/s41598-026-70027-1

Image Credits: AI Generated

DOI: 10.1038/s41598-026-70027-1

Keywords: hospital AI, medical robotics, healthcare inequality, health disparity, rural hospitals, health policy, clinical AI, surgical robots, digital health, healthcare access, technology diffusion, United States healthcare

The study, conducted by Azélie Maurice of the Department of Anthropology at Southern Methodist University in Dallas, employed a qualitative design built around five semi-structured interviews with advocates recruited through nonprofit organizations. Rather than evaluating specific programs or prevention campaigns, as much of the earlier literature has done, the research set out to understand the roots and practices of eating disorder advocacy itself. The interviews were analyzed using reflexive thematic analysis, a flexible qualitative method in which themes are developed through the researcher’s active engagement with the data rather than through rigid, pre-set coding frameworks. To sharpen the interpretation, Maurice framed the analysis through two conceptual lenses: medicalization, which describes how conditions come to be defined and treated as medical problems, and neo-pluralist interest group theory, which examines how organized groups compete to influence policy within systems where power is unevenly distributed.

Three major themes emerged from the analysis, and together they sketch both the promise and the paradox of eating disorder advocacy. The first theme, stigma as both barrier and motivator, captures a central tension in advocates’ accounts. Stigma surrounding eating disorders, the participants explained, is not merely an unpleasant social attitude; it actively shapes who gets diagnosed, who gets treated, and whose suffering is taken seriously. Stereotypes that eating disorders affect only young, thin, white, affluent women continue to exclude men, people of color, older adults, and people in larger bodies from recognition and care. Advocates reported drawing directly on their own lived experience to challenge these stereotypes, using personal narratives to humanize the illness and push for more inclusive approaches to treatment. In this sense, stigma functioned paradoxically: it was the very obstacle that fueled their commitment, transforming personal pain into public purpose.

The second theme, navigating structural constraints, shifts the focus from social attitudes to institutional architecture. Participants described in striking detail how fragmented and uneven insurance systems restrict access to eating disorder treatment. In the United States, coverage for eating disorder care varies dramatically between insurers, between states, and even between individual policies. Advocates described patients being denied residential or intensive outpatient care, being discharged before recovery because benefits ran out, and being forced into financial ruin to continue treatment. These accounts align with longstanding critiques of managed care, in which utilization review and cost-containment mechanisms can override clinical judgment about the level of care a patient needs. For eating disorders, where early and sustained intervention strongly predicts recovery, such barriers are not merely inconvenient; they can be life-threatening.

The third theme, strategic repertoires, documents the practical toolkit that advocates have developed to work within and around these constraints. Participants described deploying personal storytelling as their most powerful instrument, since narratives of lived experience can shift public opinion in ways that statistics rarely do. Alongside storytelling, advocates reported using cost-based arguments, framing eating disorders not only as a humanitarian crisis but as an economic one, in which untreated illness generates far greater downstream costs than timely treatment. Education formed a third pillar, with advocates working to inform clinicians, schools, families, and policymakers about the realities of these illnesses. Finally, coalition-building emerged as a key strategy: by forming alliances with other advocacy organizations, professional bodies, and policymakers, advocates amplify voices that would otherwise be too small to be heard in the crowded arena of health policy.

Taken together, these themes reveal what Maurice describes as a fundamental paradox at the heart of eating disorder advocacy. The movement exists to challenge stigma and promote inclusion, yet it must operate inside a healthcare system shaped by profit-driven logics and chronic resource scarcity. Advocates are simultaneously critics of the system and participants in it, pressing for reform while negotiating with insurers, providers, and institutions whose incentives may run counter to comprehensive, long-term care. This paradox, the study suggests, is not a sign of failure but a structural condition of advocacy in the American context, where movements for health justice must often fight the system using the system’s own language of cost, evidence, and market logic.

One of the study’s most compelling insights concerns the dual role of lived experience. For advocates, personal history with an eating disorder serves simultaneously as a source of personal healing and as a form of political leverage. Telling one’s story publicly can consolidate recovery, give meaning to suffering, and connect the advocate to a community of others who understand. At the same time, that same story becomes a strategic asset in meetings with legislators, insurance companies, and media outlets, where the authenticity of lived experience can accomplish what clinical data alone cannot. This dual function, however, carries its own risks, including emotional exhaustion and the pressure to repeatedly perform one’s most vulnerable moments for institutional gain, a dynamic familiar from studies of advocacy in HIV/AIDS and breast cancer movements.

The comparison with those earlier movements is instructive. Advocacy for HIV/AIDS and breast cancer has received sustained scholarly attention and is widely credited with transforming research funding, drug approval pathways, and public awareness. Eating disorder advocacy, by contrast, has rarely been studied beyond program evaluation or prevention campaigns, leaving the field without a clear account of its own history, strategies, and internal tensions. By situating eating disorder advocacy within the broader landscape of health social movements, the new research helps correct that gap and provides a framework that future scholars can extend. The findings point to patterns that likely resonate internationally, even as they emphasize how distinctly the U.S. healthcare system and political environment shape what advocates can realistically achieve.

The study also opens several avenues for future research. Maurice suggests examining the relationships between advocates and healthcare practitioners, a dynamic that can range from productive partnership to friction over treatment philosophy and resource allocation. Another promising direction is the transition from patient to advocate, a process through which individuals convert recovery into activism and renegotiate their relationship with the illness. Finally, the evolving role of social media in shaping advocacy strategies deserves close attention, as digital platforms have lowered the barriers to storytelling and coalition-building while introducing new risks around misinformation, harassment, and the commercialization of recovery narratives.

For clinicians, policymakers, and the public, the message of this research is clear. Eating disorder advocacy is not a peripheral activity but a central force in the struggle for fair and effective care, and its effectiveness depends on conditions that society controls: insurance parity, inclusive diagnostic practices, and genuine recognition of who these illnesses affect. The advocates interviewed in this study demonstrate that lived experience, when organized and amplified, can contest stigma and demand accountability from powerful institutions. But their accounts also show that individual courage cannot substitute for structural change. As eating disorders continue to rise as a public health concern in the United States, the voices documented here offer both a roadmap and a warning: progress is possible, but only if the systems that ration care are themselves made the subject of reform.

Subject of Research: A qualitative reflexive thematic analysis of the motivations, strategies, and structural challenges of eating disorder advocacy in the United States.

Article Title: Contesting care, navigating paradoxes: a thematic reflexive analysis of eating disorders advocates voices

Article References: Maurice, A. (2026). Contesting care, navigating paradoxes: a thematic reflexive analysis of eating disorders advocates voices. Journal of Eating Disorders. https://doi.org/10.1186/s40337-025-01521-6

Image Credits: AI Generated

DOI: 10.1186/s40337-025-01521-6

Keywords: eating disorders, advocacy, lived experience, stigma, insurance barriers, reflexive thematic analysis, medicalization, health policy, mental health, qualitative research, nonprofit organizations, United States healthcare